Approval of funds for embryonic research appears unlikely
- Jun 15, 2004 - comment
It is improbable a measure to fund destructive, embryonic stem cell research will make it through Congress this year.
Though most Democrats and even numerous Republicans in Congress have mounted an assault on the Bush administration’s pro-life policy on such research, the President appears to have the support of his party’s leadership in both houses
Republican Sen. Orrin Hatch of Utah said in early July, however, the Senate has more than the 60 votes needed to prevent a filibuster and bring to the floor legislation to weaken Bush’s ban on federal funding of the controversial research. While the votes for lifting the President’s restriction are in place, Hatch told CNN, he is uncertain if Congress would take action “in this hot political atmosphere,” The Associated Press reported.
Hatch, normally a trustworthy vote for the pro-life cause during his 27 years in the Senate, is one of the leaders of a congressional effort to fund the controversial research. While research on stem cells from adults and such sources as placentas and umbilical cord blood is universally supported, most pro-life advocates inside and outside Congress oppose embryonic stem cell research because it results in the destruction of donor embryos.
That has not prevented Hatch and some others with pro-life credentials in Congress from advocating the government fund the experiments, even though such privately funded research is already legal. In June, 58 senators, including 14 Republicans, wrote Bush urging him to revise his 2001 order barring federal funds for such research. That followed a similar letter in April from 206 of 435 members of the House of Representatives. Thirty-six GOP members signed onto that letter.
The White House has said the President is standing firm, and Senate Majority Leader Bill Frist and House of Representatives Speaker Dennis Hastert have indicated a bill to fund stem cell research on some embryos is unlikely to be considered as a stand-alone measure.
Reps. Michael Castle, R.-Del., and Diana DeGette, D.-Colo., introduced the Stem Cell Research Enhancement Act, H.R. 4682, in June after spearheading the House group letter to Bush. The bill would call for federal funding of research on embryos donated by patients at in vitro fertilization clinics. While action on the measure as a free-standing proposal is doubtful, the possibility remains it could gain passage as an amendment to an appropriations bill, though that appears unlikely.
Further Learning
Learn more about: Life, Stem-Cell Research